Tarsus Pharmaceuticals TARS
NASDAQ TARS
$76.95 +0.26 (+0.33%)
As of: Sep 30, 2026 · 9:46 AM EDT

Tarsus Pharmaceuticals (TARS) Operating Expenses (2019 - 2026)

Updated

Tarsus Pharmaceuticals' Operating Expenses was $193.82 million in Q2 2026, up 55.2% from $124.84 million a year earlier and up 15.2% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Operating Expenses (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Tarsus Pharmaceuticals' Operating Expenses was $654.87 million through Jun 30, 2026, up 66.4% year-over-year; for FY2025, it came in at $522.33 million, up 72.1% from FY2024.

  • Operating Expenses has now increased for six consecutive years, with a five-year compound annual growth rate of 80.9% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $303.52 million in FY2024 (+89.0%), $160.61 million in FY2023 (+81.4%), $88.53 million in FY2022 (+28.0%) and $69.18 million in FY2021 (+156.3%).
  • The Q2 2026 figure marks the highest quarterly Operating Expenses in data going back to Q3 2019.
  • Compared with a year earlier, Operating Expenses has increased for 17 straight quarters, with growth averaging 66.4% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q1 2024 (growth of 137.9%); the worst was Q1 2022 (a decline of 11.7%).
  • Per Business Quant data, TARS's Operating Expenses in the three quarters before Q2 2026 was $168.18 million (Q1 2026), $159.64 million (Q4 2025) and $133.23 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Tarsus Pharmaceuticals 3.32 Bn 2.27 Bn 161.80 Mn 193.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 193.82 Mn
Mar 31, 2026 168.18 Mn
Dec 31, 2025 159.64 Mn
Sep 30, 2025 133.23 Mn
Jun 30, 2025 124.84 Mn
Mar 31, 2025 104.62 Mn
Dec 31, 2024 90.83 Mn
Sep 30, 2024 73.28 Mn
Jun 30, 2024 74.12 Mn
Mar 31, 2024 65.30 Mn
Dec 31, 2023 57.53 Mn
Sep 30, 2023 42.81 Mn
Jun 30, 2023 32.82 Mn
Mar 31, 2023 27.45 Mn
Dec 31, 2022 25.06 Mn
Sep 30, 2022 22.91 Mn
Jun 30, 2022 20.50 Mn
Mar 31, 2022 20.06 Mn
Dec 31, 2021 14.79 Mn
Sep 30, 2021 16.95 Mn
API Access

Tarsus Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=TARS&period=max&api_key=YOUR_API_KEY